2025-05-02 20:58:20
Latest Post
Railtel Corporation of India Ltd Q4 FY2025 net profit surges to Rs. 113.45 crores
Jaiprakash Power Ventures Ltd Q4 FY25 consolidated net profit at Rs. 155.67 crores
Nuvoco Vistas Corporation Ltd Q4 FY2025 consolidated PAT soars to Rs. 165.54 crores
5paisa Capital Ltd consolidated Q4FY25 profit slides QoQ to Rs. 10.06 crores
Home First Finance Company India Ltd Q4 FY2025 PAT up at Rs. 104.69 crores
Stock Report
Samrat Pharmachem Ltd reports net profit of Rs. 1.55 crore in Q4 FY21
Posted On : 2021-07-01 19:22:43( TIMEZONE : IST )
SAMRAT PHARMACHEM LTD. has reported financial results for the period ended March 31, 2021.
Financial Results (Q4 FY20-21) - QoQ Comparison
The company has reported total income of Rs.47.73 crores during the period ended March 31, 2021 as compared to Rs.54.94 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.1.55 crores for the period ended March 31, 2021 as against net profit / (loss) of Rs.1.53 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.5.05 for the period ended March 31, 2021 as compared to Rs.4.97 for the period ended December 31, 2020.
| Financials | Q4 FY20-21 | Q3 FY20-21 | % Change |
| Total Income | ₹ 47.73 crs | ₹ 54.94 crs |  -13.12% |
| Net Profit | ₹ 1.55 crs | ₹ 1.53 crs |  1.31% |
| EPS | ₹ 5.05 | ₹ 4.97 | 1.61% |
Financial Results (Q4 FY20-21) - YoY Comparison
The company has reported total income of Rs.47.73 crores during the period ended March 31, 2021 as compared to Rs.30.35 crores during the period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.1.55 crores for the period ended March 31, 2021 as against net profit / (loss) of Rs.0.3934 crores for the period ended March 31, 2020.
The company has reported EPS of Rs.5.05 for the period ended March 31, 2021 as compared to Rs.1.27 for the period ended March 31, 2020.
| Financials | Q4 FY20-21 | Q4 FY19-20 | % Change |
| Total Income | ₹ 47.73 crs | ₹ 30.35 crs | 57.27% |
| Net Profit | ₹ 1.55 crs | ₹ 0.3934 crs | 294% |
| EPS | ₹ 5.05 | ₹ 1.27 | 297.64% |
Financial Results (Year ended FY 20-21) - YoY Comparison
The company has reported total income of Rs.179.48 crores during the 12 months period ended March 31, 2021 as compared to Rs.138.02 crores during the 12 months period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.5.33 crores for the 12 months period ended March 31, 2021 as against net profit / (loss) of Rs.4.23 crores for the 12 months period ended March 31, 2020.
The company has reported EPS of Rs.17.26 for the 12 months period ended March 31, 2021 as compared to Rs.13.71 for the 12 months period ended March 31, 2020.
| Financials | Year Ended FY20-21 | Year Ended FY19-20 | % Change |
| Total Income | ₹ 179.48 crs | ₹ 138.02 crs | 30.04% |
| Net Profit | ₹ 5.33 crs | ₹ 4.23 crs | 26% |
| EPS | ₹ 17.26 | ₹13.71 | 25.89% |
Shares of SAMRAT PHARMACHEM LTD. was last trading in BSE at Rs.237.5 as compared to the previous close of Rs. 232.65. The total number of shares traded during the day was 13385 in over 462 trades.
The stock hit an intraday high of Rs. 240 and intraday low of 220. The net turnover during the day was Rs. 3045477.
